Announcements Trials

Browse Landscape

Phase

Phase NA 2 Phase EARLY_PHASE1 1 Phase 2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 80 Genitourinary 71 Gastrointestinal 61 Other hematologic neoplasm 55 Breast 41 Thoracic 38 CNS 29 Head & Neck 25 Plasma cell 24 Myeloid 24 Sarcoma 21 Gynecologic 20 Dermatologic 14 Endocrine 12 Other solid neoplasm 9 Tumor-Agnostic 7 NET 4 Classical hematology 3 Other neoplasm 2 Other 1

Conditions

Obesity 1 Inflammation 1 Breast Neoplasms 1

Interventions

Radiotherapy 5 Surveys and Questionnaires 4 Cisplatin 4 angiotensin I (1-7) 3 alvimopan 3 Radiation 3 Injections 3 Water 2 Vitamin D 2 Tirzepatide 2 RRx-001 2 Mouthwashes 2 Metformin 2 Interleukin 1 Receptor Antagonist Protein 2 High-Intensity Focused Ultrasound Ablation 2 Drug Therapy 2 Dexmedetomidine 2 Dexamethasone 2 Calcium Dobesilate 2 Amifostine 2 Acetylcysteine 2 tempol 1 peppermint oil 1 pegfilgrastim 1 naloxegol 1 methylnaltrexone 1 methyl N-acetylsibirosaminide 1 linaclotide 1 licogliflozin 1 kang-lai-te 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Specimen Handling × Other × Clear all

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon ⚡